Modular Approaches for Diverse Molecules: Reinventing Smart Bioprocessing

By Dr. Stefan R. Schmidt, Chief Scientific Officer Rentschler Biopharma

As biopharma companies develop growing numbers of biologic therapeutics and drug budgets are squeezed worldwide, there is an increasing pressure on manufacturers to find more efficient and effective production processes. To reach this goal, Rentschler Biopharma, an independent and family-owned contract manufacturing organization (CMO) based in Laupheim, Germany, is using an approach it calls "smart bioprocessing" to create scalable manufacturing processes rapidly and efficiently.